OncoQuest Pharmaceuticals Inc (078590) — Capital Reinvestment Ratio
OncoQuest Pharmaceuticals Inc (078590) has a Capital Reinvestment Ratio of 0.15x as of March 2025, meaning it reinvests 0% of its operating cash flow (₩431.70 Million) in capital expenditures (₩62.84 Million). Check 078590 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
OncoQuest Pharmaceuticals Inc Capital Reinvestment Ratio (2014–2025)
This chart tracks OncoQuest Pharmaceuticals Inc's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see 078590 cash generation efficiency.
Annual Capital Reinvestment Ratio for OncoQuest Pharmaceuticals Inc (2014–2025)
Year-by-year Capital Reinvestment Ratio for OncoQuest Pharmaceuticals Inc from 2014 to 2025. See OncoQuest Pharmaceuticals Inc (078590) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.43x | ₩485.35 Million | ₩1.18 Billion | ▲ +283.1% |
| 2024 | 0.63x | ₩3.96 Billion | ₩2.51 Billion | ▲ +274.4% |
| 2023 | 0.17x | ₩11.19 Billion | ₩1.90 Billion | ▼ -63.1% |
| 2020 | 0.46x | ₩7.55 Billion | ₩3.48 Billion | ▼ -50.1% |
| 2018 | 0.92x | ₩1.44 Billion | ₩1.33 Billion | ▲ +245.5% |
| 2017 | 0.27x | ₩4.79 Billion | ₩1.28 Billion | ▼ -41.2% |
| 2016 | 0.45x | ₩3.54 Billion | ₩1.61 Billion | ▼ -56.4% |
| 2015 | 1.04x | ₩2.79 Billion | ₩2.91 Billion | ▼ -10.4% |
| 2014 | 1.16x | ₩1.02 Billion | ₩1.18 Billion | — |